Plain-English translation of NCT07692256 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Heart Failure research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This is a research study testing whether a medication called empagliflozin can help children and teenagers whose hearts aren't pumping well. Half of the participants will take the medication for 90 days along with their regular heart medicines, while the other half will continue with standard care alone. Researchers want to see if this treatment can improve how their hearts work and how they feel.
Heart failure in children is serious and difficult to treat with current medicines alone. Doctors hope this medication, which has shown promise in adults, might offer a new option to help young patients feel better and live healthier lives.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to either receive the new medication or continue with standard care only. If you receive the medication, you'll take a daily dose by mouth (or crushed and mixed with water if you can't swallow pills) for 90 days, along with your regular heart medicines. Your doctor will check your urine within one week to see how the medication is working and may adjust your dose. You'll have follow-up visits to monitor how you're doing throughout the study.
AI-generated summary from trial data · Aug 6, 2026 · Not medical advice
Egypt
Phase
Testing effectiveness
Sponsor
Ain Shams University
Enrollment target
~60 participants
Started
December 2025
Primary completion
December 2026
Age range
1 Month – 18 Years
Last updated on clinicaltrials.gov in July 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
nassar elsayed nassar, master candidate
Ain Shams University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.